Synlab

SYAB.VIPhase 1

Munich, GermanyFounded 1994synlab.com

SYNLAB is a fundamental part of national healthcare systems, providing actionable diagnostic information for healthy lives and well-being for all. With €2.62 billion in revenue in 2024 and over 24,000 employees including 2,000+ medical experts, the company leverages its extensive European footprint and scientific expertise to deliver reliable, high-quality diagnostics. SYNLAB's mission focuses on leadership through excellence in service, driving scientific innovation, and maintaining a value-based approach centered on passion, accountability, and customer centricity.

Market Cap

$3.3B

Founded

1994

Employees

24,000+

Focus

Diagnostics

AI Company Overview

Technology Platform

Integrated network of over 350 laboratories utilizing standardized processes, advanced specialty testing capabilities in genomics and rare diseases, and digital infrastructure for efficient sample tracking and result delivery.

Pipeline Snapshot

1 drug in pipeline

Drug	Indication	Stage
MGB-BP-3	Healthy	Phase 1

Opportunities

Growing demand for diagnostic services driven by aging populations, increased focus on preventive healthcare, and expansion of personalized medicine.

SYNLAB's scale and specialty expertise position it to capture market share in high-growth areas like genomic testing and rare disease diagnostics across its extensive European network.

Risk Factors

Faces regulatory and reimbursement pressures across multiple countries, integration challenges from acquisitions, talent competition for medical experts, and potential technological disruption from point-of-care and digital testing alternatives.

Economic sensitivity to healthcare budget constraints represents additional risk.

Competitive Landscape

Competes with other European diagnostic providers like Eurofins, Cerba, Unilabs, and Sonic Healthcare, as well as national and regional laboratories. SYNLAB differentiates through its scale as Europe's largest network, standardized quality across countries, deep specialty expertise with over 2,000 medical experts, and strong ESG focus integrated into operations.

Publications

Pipeline